<DOC>
	<DOCNO>NCT00366678</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability immunogenicity 13-valent pneumococcal conjugate ( 13vPnC ) vaccine compare Prevenar ( 7vPnC ) , give concomitantly routine pediatric vaccine France .</brief_summary>
	<brief_title>Study Evaluate 13-valent Pneumococcal Conjugate Vaccine Infants</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2monthold infant . Available entire study period . Exclusion criterion : Â· Known contraindication vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>Vaccine</keyword>
</DOC>